"Augusta Oncology's Downtown location on D'Antignac Street is conveniently located in the Professional Office Building just across the street from University Hospital, with on-site parking. Our private practice offers the most comprehensive, compassionate cancer care and blood disorder treatment for Augusta, GA and surrounding areas. We also offer outpatient infusion treatments for various conditions."

During the past decade, Augusta Oncology Associates PC-D'Antignac conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 5 clinical trials were completed, i.e. on average, 38.5% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 3 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Augusta Oncology Associates PC-D'Antignac" #1 collaborator was "National Cancer Institute (NCI)" with 8 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator and "NRG Oncology" with 2 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Augusta Oncology Associates PC-D'Antignac" are "Invasive Breast Carcinoma" (3 trials), "Lynch Syndrome" (2 trials), "Stage II Breast Cancer" (2 trials), "Stage III Breast Cancer AJCC v7" (2 trials) and "Stage IIIA Breast Cancer" (2 trials). Many other conditions were trialed in "Augusta Oncology Associates PC-D'Antignac" in a lesser frequency.

Most popular intervention types in "Augusta Oncology Associates PC-D'Antignac" are "Drug" (16 trials), "Other" (16 trials), "Biological" (8 trials), "Procedure" (6 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (9 trials), "Questionnaire Administration" (7 trials), "Biospecimen Collection" (5 trials), "Laboratory Biomarker Analysis" (5 trials) and "Computed Tomography" (4 trials). Other intervention names were less common.

The vast majority of trials in "Augusta Oncology Associates PC-D'Antignac" are 15 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Augusta Oncology Associates PC-D'Antignac". undefined are not yet recruiting, 5 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Augusta Oncology Associates PC-D'Antignac, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Augusta Oncology Associates PC-D'Antignac, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".